Free Trial

Healthpeak Properties (NYSE:DOC) Rating Increased to Hold at Wall Street Zen

Healthpeak Properties logo with Finance background

Healthpeak Properties (NYSE:DOC - Get Free Report) was upgraded by Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued to investors on Sunday.

DOC has been the subject of a number of other research reports. Scotiabank cut their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research report on Monday, May 12th. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Argus reaffirmed a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Finally, Evercore ISI dropped their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $23.27.

Get Our Latest Report on DOC

Healthpeak Properties Stock Performance

NYSE:DOC opened at $17.35 on Friday. The firm has a 50 day simple moving average of $17.47 and a 200-day simple moving average of $19.11. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a market cap of $12.05 billion, a PE ratio of 43.36, a P/E/G ratio of 1.98 and a beta of 1.04. Healthpeak Properties has a 1-year low of $16.64 and a 1-year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The company's revenue was up 15.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.45 earnings per share. On average, equities analysts expect that Healthpeak Properties will post 1.86 EPS for the current year.

Insider Activity

In related news, CEO Scott M. Brinker acquired 2,750 shares of Healthpeak Properties stock in a transaction on Friday, May 9th. The shares were purchased at an average cost of $17.39 per share, for a total transaction of $47,822.50. Following the purchase, the chief executive officer now directly owns 204,613 shares of the company's stock, valued at $3,558,220.07. The trade was a 1.36% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Tommy G. Thompson acquired 5,777 shares of Healthpeak Properties stock in a transaction on Wednesday, May 28th. The shares were bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the purchase, the director now directly owns 144,290 shares in the company, valued at $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders bought 29,764 shares of company stock worth $521,909. 0.23% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Douglas Lane & Associates LLC lifted its position in shares of Healthpeak Properties by 8.5% in the 1st quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock worth $56,471,000 after buying an additional 218,395 shares during the last quarter. Ibex Wealth Advisors bought a new position in shares of Healthpeak Properties in the 1st quarter worth about $5,056,000. Vert Asset Management LLC lifted its position in shares of Healthpeak Properties by 6.9% in the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock worth $6,574,000 after buying an additional 20,924 shares during the last quarter. Two Sigma Advisers LP bought a new position in shares of Healthpeak Properties in the 4th quarter worth about $5,691,000. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of Healthpeak Properties by 6.9% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock worth $7,229,000 after buying an additional 23,135 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Further Reading

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines